Predicting pathological response to neoadjuvant or conversion chemoimmunotherapy in stage IB–III non‐small cell lung cancer patients using radiomic features

BACKGROUND: To develop a radiomics model based on chest computed tomography (CT) for the prediction of a pathological complete response (pCR) after neoadjuvant or conversion chemoimmunotherapy (CIT) in patients with non‐small cell lung cancer (NSCLC). METHODS: Patients with stage IB–III NSCLC who re...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Nong, Yue, Hai‐Lin, Zhang, Bai‐Hua, Chen, Juan, Chu, Qian, Wang, Jian‐Xin, Yu, Xiao‐Ping, Jian, Lian, Bin, Ya‐Wen, Liu, Si‐Ye, Liu, Jin, Zeng, Liang, Yang, Hai‐Yan, Zhou, Chun‐Hua, Jiang, Wen‐Juan, Liu, Li, Zhang, Yong‐Chang, Xiong, Yi, Wang, Zhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542462/
https://www.ncbi.nlm.nih.gov/pubmed/37596822
http://dx.doi.org/10.1111/1759-7714.15052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542462/
https://www.ncbi.nlm.nih.gov/pubmed/37596822
http://dx.doi.org/10.1111/1759-7714.15052

Ejemplares similares